Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...
Navigation Menu Toggle navigation Sign in Product ...
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12 ...
Hosted on MSN2d
CBSE Board Exams: From Sample Paper Questions To Use Of Whiteners — All You Need To KnowWith the CBSE Board Exams 2025 approaching, students should be aware of the key changes and updates announced by the Central ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback